从静息到增殖:驱动Malassez上皮细胞活化并向炎性根尖囊肿转化的分子机制
综述提出上皮、间质与免疫三方阈值协同突破ERM静息状态是囊性转化的关键,并构建了以生物标志物群预测病变行为的理论框架。
要点
- FGF-7维持ERM增殖稳态,TGF-β/Smad2/3与IGF-BP-6隔离IGF-II共同维持上皮静息。
- IGF-BP-6蛋白水解释放IGF-II、EGF/EGF-R上调及IL-1β/NF-κB拮抗TGF-β抑制促进ERM病理性增殖。
- M1巨噬细胞极化与Th1/Th17优势及活化树突状细胞强化微环境,推动选择性囊性转化。
核心结论
- 并非所有含上皮的根尖肉芽肿均进展为炎性根尖囊肿,囊性转化需上皮、间质和免疫阈值协同突破ERM静息状态。
- ERM应被重新定义为动态的、炎症响应性祖细胞,其活化依赖免疫-上皮交互而非单纯感染。
主要发现
- FGF-7激活FGFR2-IIIb-MAPK/PI3K-AKT通路维持ERM增殖稳态。
- TGF-β1/β2与Smad2/3信号维持上皮静息,IGF-BP-6隔离生物可利用IGF-II避免促有丝分裂信号。
- IGF-BP-6蛋白水解释放生物活性IGF-II增强ERM病理性增殖。
- 强烈根尖周炎上调EGF及其受体EGF-R,促进ERM失控增殖。
- IL-1β通过NF-κB(p65)活化拮抗TGF-β/Smad2抑制,IL-6经经典和反式信号促进ERM病理性增殖与迁移。
关键数值与推荐
- FGF-7/FGFR2-IIIb-MAPK/PI3K-AKT通路维持ERM增殖稳态。
- TGF-β1/β2-Smad2/3信号和IGF-BP-6隔离IGF-II维持ERM静息。
- IGF-BP-6水解释放IGF-II、EGF/EGF-R上调、IL-1β/NF-κB及IL-6信号驱动ERM病理性增殖。
- 提出上皮、免疫/共刺激和间质/重塑三类生物标志物群以预测病变行为。
临床怎么用
- 基于上皮、免疫/共刺激和间质/重塑生物标志物群预测含上皮根尖肉芽肿的囊性转化风险。
- 为分子引导诊断和靶向治疗策略提供理论框架,以预防或逆转囊性转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammatory radicular cysts (IRCs) arise from periapical granulomas (PGs). IRCs originate from Malassez epithelial remnants (ERMs), which can proliferate under specific biological stimuli. Although ERMs are common within PGs, only a subset of lesions evolves into IRCs, suggesting that specific molecular and immunoregulatory mechanisms govern this selective transformation. OBJECTIVES: Molecular mechanisms and cellular signalling pathways modulating the epithelial proliferation of the ERM represent an inflexion point in the progression from PG to IRC. The objective of this review is to analyse the mechanisms and pathways involved in uncontrolled ERM proliferation, intending to elucidate why only a subset of epithelium-containing PGs progress to IRCs. METHODS: A systematic literature search was conducted across MEDLINE (PubMed), Web of Science and Scopus from inception to July 2025. Sixty-one articles met the inclusion criteria for narrative analysis and synthesis. RESULTS: ERM proliferation emerges from a coordinated interplay between immune, stromal and epithelial compartments. Fibroblast growth factor-7 (FGF-7/KGF) activates the FGFR2-IIIb-MAPK/PI3K-AKT pathways, maintaining homeostasis of ERM proliferation. Transforming growth factor-β (TGF-β1/β2) and Smad2/3 signalling sustain epithelial quiescence. IGF-BP-6 sequesters bioavailable insulin growth factor (IGF-II), avoiding mitogenic signalling. Proteolytic cleavage of IGF-BP-6 releases bioactive IGF-II, enhancing ERM pathological proliferation. Intense AP upregulates epidermal growth factor (EGF) and its receptor (EGF-R), promoting uncontrolled ERM proliferation. IL-1β antagonises TGF-β/Smad2 suppression through NF-κB (p65) activation. IL-6 promotes pathological ERM proliferation and migration via classic and trans-signalling. Persistent M1 macrophage polarisation and Th1/Th17 dominance reinforce this microenvironment. Activated dendritic cells potentiate T-cell responses and cytokine release. CONCLUSION: Not all PGs progress to IRCs because cystic transformation requires the convergence of epithelial, stromal and immune thresholds that override ERM quiescence. This review proposes an integrative theoretical model that redefines ERMs as dynamic, inflammation-responsive progenitors whose activation depends on immune-epithelial cross-talk rather than infection alone. By delineating specific biomarker clusters-epithelial, immune/co-stimulatory and stromal/remodelling-this work proposes a mechanistic framework capable of predicting lesion behaviour. It may establish the foundation for molecularly guided diagnosis and the rational design of targeted therapeutic strategies aimed at preventing or reversing cystic transformation, ultimately bridging molecular insight with clinical endodontic practice.
引用
- Ríos-Osorio N, Caviedes-Bucheli J, Sosa-Gutierrez J, et al. From Quiescence to Proliferation: Molecular Mechanisms Driving Malassez Epithelial Cell Activation and Proliferation Into Inflammatory Radicular Cystic Transformation. Int Endod J. 2025. PMID: 41253728. doi:10.1111/iej.70062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。